Length 390 pages

Date published October 2008

Print copies are available upon request. Call 781-972-5444. 

For Corporate Subscriptions, Multi-Reports Orders, Discounts or Order Questions.  

Contact:
Kerri Kelley
Customer Service
781-972-1347 



Immunotherapies and Vaccines for Cancer and Infectious Diseases Tables and Figures

 

Author: Lucy J. Sannes, PhD, MBA

Tables

Table 2.1. Incidence and Prevalence of Selected Cancers in the United States, 2008
Table 2.2. Five-Year Relative Survival Rates by Stage of Diagnosis (1996–2003) for Major Cancers Targeted by Immunotherapies and Cancer Vaccines
Table 3.1. Selected Chemotherapy Drugs that Are FDA Approved for Treatment of Cancer
Table 3.2. Selected Chemotherapy Drugs Approved by the FDA for Treatment of Brain Cancer
Table 3.3. Selected Drugs Approved by the FDA for Treatment of Breast Cancer
Table 3.4. Selected Drugs Approved by the FDA for Treatment of Cervical Cancer
Table 3.5. Selected Drugs Approved by the FDA for Treatment of Colorectal Cancer
Table 3.6. Selected Drugs Approved by the FDA for Treatment of Leukemia
Table 3.7. Selected Drugs Approved by the FDA for Treatment of Lung Cancer (Including NSCLC and SCLC)
Table 3.8. Selected Drugs Approved by the FDA for Treatment of Non–Hodgkin’s Lymphoma
Table 3.9. Selected Drugs Approved by the FDA for Treatment of Melanoma
Table 3.10. Selected Drugs Approved by the FDA for Treatment of Ovarian Cancer
Table 3.11. Selected Drugs Approved by the FDA for Treatment of Advanced or Metastatic Pancreatic Cancer
Table 3.12. Selected Drugs Approved by the FDA for Treatment of Prostate Cancer
Table 3.13. Selected Drugs Approved by the FDA for Treatment of Advanced or Metastatic Renal Cell Carcinoma
Table 3.14. Selected Passive Immunotherapies for Prevention of Infectious Disease Infection and Other Indications
Table 3.15. Selected Active Immunotherapies Approved by the FDA for Treatment of Infectious Diseases
Table 3.16. FDA-Licensed Infectious Disease Vaccines
Table 5.1. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Brain Cancer
Table 5.2. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Breast Cancer
Table 5.3. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Colorectal Cancer
Table 5.4. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Leukemia
Table 5.5. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Lung Cancer
Table 5.6. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Lymphoma (Non–Hodgkin’s Lymphoma)
Table 5.7. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Melanoma
Table 5.8. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Ovarian Cancer
Table 5.9. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Pancreatic Cancer
Table 5.10. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Prostate Cancer
Table 5.11. Selected Cancer Immunotherapies and Vaccines in Clinical Trials for Treatment of Renal Cancer
Table 5.12. Selected Immunotherapies and Vaccines in Development for Other or Nonspecified Cancer Indications
Table 6.1. Selected Anthrax and Other Biodefense Vaccines in Development
Table 6.2. Selected Vaccines in Development to Protect Against Campylobacter and/or Enterotoxigenic Escherichia coli Infections (Traveler’s Diarrhea)
Table 6.3. Selected Vaccines in Development for Cytomegalovirus
Table 6.4. Selected Vaccines in Development for Dengue
Table 6.5. Selected Vaccines in Development for Encephalitis
Table 6.6. Selected Vaccines and/or Immunotherapies in Development for Prevention or Treatment of Hepatitis B Virus Infection
Table 6.7. Selected Vaccines and/or Immunotherapies in Development for Prevention or Treatment of Hepatitis C Virus Infection
Table 6.8. Selected Vaccines in Development for Herpes Simplex Virus Infection (Genital Herpes)
Table 6.9. Selected Vaccines and/or Immunotherapies in Development for Human Immunodeficiency Virus (HIV) Infection
Table 6.10. Selected Vaccines and/or Immunotherapies in Development for Human Papillomavirus (HPV) for Prevention or Treatment of Cervical Dysplasia or Cancer
Table 6.11. Selected Vaccines and/or Immunotherapies in Development for Influenza
Table 6.12. Selected Vaccines and/or Immunotherapies in Development for Malaria
Table 6.13. Selected Vaccines and/or Immunotherapies in Development for Meningococcal Disease (Neisseria meningitidis)
Table 6.14. Selected Vaccines and/or Immunotherapies in Development for Pneumococcal Disease (Streptococcus pneumoniae)
Table 6.15. Selected Vaccines in Development for Respiratory Syncytial Virus (RSV)
Table 6.16. Selected Vaccines in Development for Tuberculosis (TB)
Table 6.17. Selected Vaccines and/or Immunotherapies in Development for West Nile Virus (WNV)
Table 6.18. Selected Combination Vaccines in Development
Table 6.19. Selected Vaccines and/or Immunotherapies in Development for Other Infectious Diseases